Is NCT03432195 results overdue?

Yes — results are overdue. Primary completion was 2018-06-28; the FDAAA-801 reporting deadline (2019-06-28) passed 2596 days ago and no results are posted on ClinicalTrials.gov.

A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations

NCT ID	NCT03432195 ↗
Sponsor	Corium, Inc. (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-06-28 (ACTUAL)
Reporting deadline	2019-06-28 (completion + 365d)
Days overdue	2596
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `74fd41cd3444c9c9…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03432195. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.